US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 24.800
  • -1.220-4.69%
Close Nov 15 16:00 ET
  • 24.949
  • +0.149+0.60%
Post 19:59 ET
140.54BMarket Cap33.07P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jul 2, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-77.47%9.95B
-84.14%7.1B
-40.27%11.93B
-44.18%12.69B
-44.18%12.69B
22.31%44.18B
34.47%44.79B
-16.42%19.97B
-26.83%22.73B
-26.83%22.73B
-Cash and cash equivalents
-65.31%1.09B
-60.03%1.05B
-66.81%719M
585.82%2.85B
585.82%2.85B
142.53%3.15B
47.87%2.63B
-12.31%2.17B
-78.60%416M
-78.60%416M
-Short-term investments
-78.41%8.86B
-85.65%6.05B
-37.04%11.21B
-55.92%9.84B
-55.92%9.84B
17.83%41.03B
33.72%42.15B
-16.90%17.81B
-23.38%22.32B
-23.38%22.32B
Receivables
17.94%17.69B
12.38%15.09B
-1.44%15.22B
4.31%15.16B
4.31%15.16B
-19.43%15B
-24.32%13.43B
-5.49%15.45B
-7.72%14.53B
-7.72%14.53B
-Accounts receivable
30.35%14.45B
11.36%11.39B
-10.69%10.99B
2.05%11.18B
2.05%11.18B
-31.04%11.09B
-32.49%10.23B
-6.96%12.31B
-4.59%10.95B
-4.59%10.95B
-Taxes receivable
-17.21%3.24B
15.65%3.69B
34.81%4.23B
11.21%3.98B
11.21%3.98B
53.97%3.92B
23.65%3.19B
0.74%3.14B
-16.15%3.58B
-16.15%3.58B
Inventory
14.87%11.72B
11.03%11.45B
14.16%10.89B
13.45%10.19B
13.45%10.19B
7.26%10.2B
-1.38%10.31B
-4.39%9.54B
-0.86%8.98B
-0.86%8.98B
Other current assets
-16.61%3.86B
-13.20%4.19B
-14.61%4.37B
5.62%5.3B
5.62%5.3B
-24.78%4.62B
-19.15%4.83B
21.85%5.12B
31.34%5.02B
31.34%5.02B
Total current assets
-41.60%43.22B
-48.43%37.83B
-15.30%42.42B
-15.46%43.33B
-15.46%43.33B
5.13%74.01B
8.72%73.35B
-7.98%50.08B
-14.13%51.26B
-14.13%51.26B
Non current assets
Net PPE
3.80%18.54B
8.40%18.96B
10.27%18.8B
16.38%18.94B
16.38%18.94B
15.68%17.86B
14.72%17.49B
12.86%17.05B
9.35%16.27B
9.35%16.27B
-Gross PPE
4.68%35.22B
7.53%35.53B
7.98%35.17B
11.25%34.99B
11.25%34.99B
10.76%33.64B
9.36%33.04B
6.89%32.57B
4.98%31.45B
4.98%31.45B
-Accumulated depreciation
-5.68%-16.68B
-6.54%-16.57B
-5.47%-16.36B
-5.74%-16.05B
-5.74%-16.05B
-5.68%-15.78B
-3.91%-15.55B
-1.02%-15.51B
-0.66%-15.17B
-0.66%-15.17B
Goodwill and other intangible assets
40.11%128.56B
39.48%129.69B
41.34%132.13B
40.04%132.68B
40.04%132.68B
18.25%91.75B
17.76%92.98B
16.81%93.48B
27.42%94.75B
27.42%94.75B
-Goodwill
33.08%68.57B
32.72%68.45B
34.62%69.3B
31.94%67.78B
31.94%67.78B
4.22%51.53B
3.37%51.57B
2.52%51.48B
4.40%51.38B
4.40%51.38B
-Other intangible assets
49.13%59.99B
47.90%61.24B
49.59%62.83B
49.64%64.9B
49.64%64.9B
42.89%40.22B
42.46%41.41B
40.87%42B
72.47%43.37B
72.47%43.37B
Investments and advances
-24.41%10.76B
-26.01%11.15B
-21.23%11.61B
1.98%15.37B
1.98%15.37B
2.52%14.24B
-20.55%15.07B
-28.90%14.74B
-30.00%15.07B
-30.00%15.07B
Non current deferred assets
-5.28%7.91B
-4.77%7.87B
-32.32%4.94B
-44.63%3.71B
-44.63%3.71B
17.01%8.35B
17.98%8.26B
28.83%7.3B
100.33%6.69B
100.33%6.69B
Other non current assets
19.05%10.49B
-17.79%10.71B
-13.64%11.2B
-5.26%12.47B
-5.26%12.47B
-19.12%8.81B
70.10%13.03B
64.55%12.97B
71.42%13.16B
71.42%13.16B
Total non current assets
24.99%176.25B
21.49%178.37B
22.77%178.68B
25.51%183.17B
25.51%183.17B
12.86%141.01B
14.86%146.82B
12.45%145.54B
19.84%145.94B
19.84%145.94B
Total assets
2.07%219.48B
-1.81%216.19B
13.02%221.1B
14.86%226.5B
14.86%226.5B
10.07%215.02B
12.74%220.17B
6.41%195.62B
8.67%197.21B
8.67%197.21B
Liabilities
Current liabilities
Payables
13.20%8.19B
-8.42%10.37B
8.54%8.78B
6.84%11.43B
6.84%11.43B
-37.53%7.24B
-4.06%11.32B
-6.81%8.09B
17.66%10.7B
17.66%10.7B
-accounts payable
-0.45%5.31B
-16.03%5.11B
-8.69%5.59B
-1.45%6.71B
-1.45%6.71B
-14.82%5.34B
-2.05%6.08B
11.21%6.12B
22.07%6.81B
22.07%6.81B
-Total tax payable
51.58%2.88B
-1.50%2.88B
62.11%3.19B
48.02%2.35B
48.02%2.35B
-38.20%1.9B
-12.60%2.93B
-38.02%1.97B
25.36%1.59B
25.36%1.59B
-Dividends payable
--0
2.81%2.38B
--0
3.00%2.37B
3.00%2.37B
--0
3.12%2.32B
--0
2.40%2.3B
2.40%2.3B
Current debt and capital lease obligation
280.65%9.7B
199.72%11.94B
96.49%8.23B
252.62%10.35B
252.62%10.35B
-36.68%2.55B
-33.19%3.99B
558.65%4.19B
30.92%2.93B
30.92%2.93B
-Current debt
280.65%9.7B
199.72%11.94B
96.49%8.23B
252.62%10.35B
252.62%10.35B
-36.68%2.55B
-33.19%3.99B
558.65%4.19B
30.92%2.93B
30.92%2.93B
Current deferred liabilities
-8.35%2.02B
96.58%2.53B
42.97%2.5B
7.14%2.7B
7.14%2.7B
-64.40%2.2B
-66.19%1.29B
-43.69%1.75B
-17.84%2.52B
-17.84%2.52B
Other current liabilities
18.73%19.92B
2.06%16.41B
-7.23%18.79B
-9.02%20.54B
-9.02%20.54B
-14.69%16.78B
-32.55%16.08B
-17.64%20.25B
-9.46%22.58B
-9.46%22.58B
Current liabilities
38.78%43.21B
26.47%43.82B
10.76%40.5B
13.42%47.79B
13.42%47.79B
-29.74%31.14B
-26.92%34.65B
-6.89%36.56B
-1.25%42.14B
-1.25%42.14B
Non current liabilities
Long term debt and capital lease obligation
-6.77%56.92B
-7.53%56.73B
96.75%60.48B
89.50%60.5B
89.50%60.5B
92.87%61.05B
84.98%61.36B
-10.69%30.74B
-8.15%31.93B
-8.15%31.93B
-Long term debt
-6.77%56.92B
-7.53%56.73B
96.75%60.48B
89.50%60.5B
89.50%60.5B
92.87%61.05B
84.98%61.36B
-10.69%30.74B
-8.15%31.93B
-8.15%31.93B
Non current deferred liabilities
91.82%2.16B
80.76%2.23B
-12.75%931M
-37.44%640M
-37.44%640M
82.63%1.13B
120.79%1.23B
62.90%1.07B
193.12%1.02B
193.12%1.02B
Employee benefits
-4.29%2.07B
-6.59%2.04B
-4.73%2.08B
-3.69%2.17B
-3.69%2.17B
-26.82%2.17B
-32.94%2.18B
-37.64%2.18B
-39.58%2.25B
-39.58%2.25B
Derivative product liabilities
--1.08B
--773M
-14.08%830M
8.34%1.04B
8.34%1.04B
----
----
-22.10%966M
-33.31%959M
-33.31%959M
Other non current liabilities
9.32%15.57B
20.07%16.09B
16.25%15.12B
25.47%16.54B
25.47%16.54B
16.37%14.24B
18.49%13.4B
23.79%13.01B
35.28%13.18B
35.28%13.18B
Total non current liabilities
-3.43%83.71B
-2.12%84.4B
52.27%88.04B
51.17%89.42B
51.17%89.42B
49.08%86.68B
42.74%86.23B
-6.57%57.82B
-3.57%59.15B
-3.57%59.15B
Total liabilities
7.72%126.92B
6.07%128.22B
36.19%128.54B
35.47%137.21B
35.47%137.21B
14.99%117.82B
12.11%120.88B
-6.70%94.38B
-2.62%101.29B
-2.62%101.29B
Shareholders'equity
Share capital
0.42%480M
0.42%480M
0.42%480M
0.42%478M
0.42%478M
0.42%478M
0.42%478M
0.42%478M
0.63%476M
0.63%476M
-common stock
0.42%480M
0.42%480M
0.42%480M
0.42%478M
0.42%478M
0.42%478M
0.42%478M
0.42%478M
0.63%476M
0.63%476M
-Preferred stock
----
----
----
--0
--0
----
----
----
--0
--0
Retained earnings
-4.23%121.06B
-9.47%116.6B
-7.46%121.32B
-5.81%118.35B
-5.81%118.35B
2.80%126.41B
10.45%128.8B
17.90%131.1B
21.53%125.66B
21.53%125.66B
Paid-in capital
1.06%93.48B
0.94%93.2B
0.92%93B
0.90%92.63B
0.90%92.63B
1.24%92.5B
1.26%92.33B
1.44%92.15B
1.34%91.8B
1.34%91.8B
Less: Treasury stock
0.24%114.76B
0.24%114.76B
0.25%114.76B
0.45%114.49B
0.45%114.49B
0.47%114.49B
0.48%114.48B
0.48%114.47B
2.34%113.97B
2.34%113.97B
Gains losses not affecting retained earnings
-0.05%-7.97B
3.53%-7.82B
6.41%-7.76B
4.13%-7.96B
4.13%-7.96B
3.14%-7.97B
-13.81%-8.1B
-34.63%-8.29B
-40.84%-8.3B
-40.84%-8.3B
Other equity interest
0.00%1M
----
----
----
----
200.00%1M
----
0.00%-1M
----
----
Total stockholders'equity
-4.80%92.29B
-11.43%87.7B
-8.60%92.28B
-6.95%89.01B
-6.95%89.01B
4.65%96.93B
13.54%99.02B
22.50%100.97B
23.91%95.66B
23.91%95.66B
Noncontrolling interests
0.74%272M
0.36%275M
3.76%276M
7.03%274M
7.03%274M
4.25%270M
4.98%274M
1.92%266M
-2.29%256M
-2.29%256M
Total equity
-4.78%92.56B
-11.40%87.98B
-8.57%92.56B
-6.91%89.29B
-6.91%89.29B
4.64%97.2B
13.52%99.29B
22.44%101.24B
23.82%95.92B
23.82%95.92B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jul 2, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -77.47%9.95B-84.14%7.1B-40.27%11.93B-44.18%12.69B-44.18%12.69B22.31%44.18B34.47%44.79B-16.42%19.97B-26.83%22.73B-26.83%22.73B
-Cash and cash equivalents -65.31%1.09B-60.03%1.05B-66.81%719M585.82%2.85B585.82%2.85B142.53%3.15B47.87%2.63B-12.31%2.17B-78.60%416M-78.60%416M
-Short-term investments -78.41%8.86B-85.65%6.05B-37.04%11.21B-55.92%9.84B-55.92%9.84B17.83%41.03B33.72%42.15B-16.90%17.81B-23.38%22.32B-23.38%22.32B
Receivables 17.94%17.69B12.38%15.09B-1.44%15.22B4.31%15.16B4.31%15.16B-19.43%15B-24.32%13.43B-5.49%15.45B-7.72%14.53B-7.72%14.53B
-Accounts receivable 30.35%14.45B11.36%11.39B-10.69%10.99B2.05%11.18B2.05%11.18B-31.04%11.09B-32.49%10.23B-6.96%12.31B-4.59%10.95B-4.59%10.95B
-Taxes receivable -17.21%3.24B15.65%3.69B34.81%4.23B11.21%3.98B11.21%3.98B53.97%3.92B23.65%3.19B0.74%3.14B-16.15%3.58B-16.15%3.58B
Inventory 14.87%11.72B11.03%11.45B14.16%10.89B13.45%10.19B13.45%10.19B7.26%10.2B-1.38%10.31B-4.39%9.54B-0.86%8.98B-0.86%8.98B
Other current assets -16.61%3.86B-13.20%4.19B-14.61%4.37B5.62%5.3B5.62%5.3B-24.78%4.62B-19.15%4.83B21.85%5.12B31.34%5.02B31.34%5.02B
Total current assets -41.60%43.22B-48.43%37.83B-15.30%42.42B-15.46%43.33B-15.46%43.33B5.13%74.01B8.72%73.35B-7.98%50.08B-14.13%51.26B-14.13%51.26B
Non current assets
Net PPE 3.80%18.54B8.40%18.96B10.27%18.8B16.38%18.94B16.38%18.94B15.68%17.86B14.72%17.49B12.86%17.05B9.35%16.27B9.35%16.27B
-Gross PPE 4.68%35.22B7.53%35.53B7.98%35.17B11.25%34.99B11.25%34.99B10.76%33.64B9.36%33.04B6.89%32.57B4.98%31.45B4.98%31.45B
-Accumulated depreciation -5.68%-16.68B-6.54%-16.57B-5.47%-16.36B-5.74%-16.05B-5.74%-16.05B-5.68%-15.78B-3.91%-15.55B-1.02%-15.51B-0.66%-15.17B-0.66%-15.17B
Goodwill and other intangible assets 40.11%128.56B39.48%129.69B41.34%132.13B40.04%132.68B40.04%132.68B18.25%91.75B17.76%92.98B16.81%93.48B27.42%94.75B27.42%94.75B
-Goodwill 33.08%68.57B32.72%68.45B34.62%69.3B31.94%67.78B31.94%67.78B4.22%51.53B3.37%51.57B2.52%51.48B4.40%51.38B4.40%51.38B
-Other intangible assets 49.13%59.99B47.90%61.24B49.59%62.83B49.64%64.9B49.64%64.9B42.89%40.22B42.46%41.41B40.87%42B72.47%43.37B72.47%43.37B
Investments and advances -24.41%10.76B-26.01%11.15B-21.23%11.61B1.98%15.37B1.98%15.37B2.52%14.24B-20.55%15.07B-28.90%14.74B-30.00%15.07B-30.00%15.07B
Non current deferred assets -5.28%7.91B-4.77%7.87B-32.32%4.94B-44.63%3.71B-44.63%3.71B17.01%8.35B17.98%8.26B28.83%7.3B100.33%6.69B100.33%6.69B
Other non current assets 19.05%10.49B-17.79%10.71B-13.64%11.2B-5.26%12.47B-5.26%12.47B-19.12%8.81B70.10%13.03B64.55%12.97B71.42%13.16B71.42%13.16B
Total non current assets 24.99%176.25B21.49%178.37B22.77%178.68B25.51%183.17B25.51%183.17B12.86%141.01B14.86%146.82B12.45%145.54B19.84%145.94B19.84%145.94B
Total assets 2.07%219.48B-1.81%216.19B13.02%221.1B14.86%226.5B14.86%226.5B10.07%215.02B12.74%220.17B6.41%195.62B8.67%197.21B8.67%197.21B
Liabilities
Current liabilities
Payables 13.20%8.19B-8.42%10.37B8.54%8.78B6.84%11.43B6.84%11.43B-37.53%7.24B-4.06%11.32B-6.81%8.09B17.66%10.7B17.66%10.7B
-accounts payable -0.45%5.31B-16.03%5.11B-8.69%5.59B-1.45%6.71B-1.45%6.71B-14.82%5.34B-2.05%6.08B11.21%6.12B22.07%6.81B22.07%6.81B
-Total tax payable 51.58%2.88B-1.50%2.88B62.11%3.19B48.02%2.35B48.02%2.35B-38.20%1.9B-12.60%2.93B-38.02%1.97B25.36%1.59B25.36%1.59B
-Dividends payable --02.81%2.38B--03.00%2.37B3.00%2.37B--03.12%2.32B--02.40%2.3B2.40%2.3B
Current debt and capital lease obligation 280.65%9.7B199.72%11.94B96.49%8.23B252.62%10.35B252.62%10.35B-36.68%2.55B-33.19%3.99B558.65%4.19B30.92%2.93B30.92%2.93B
-Current debt 280.65%9.7B199.72%11.94B96.49%8.23B252.62%10.35B252.62%10.35B-36.68%2.55B-33.19%3.99B558.65%4.19B30.92%2.93B30.92%2.93B
Current deferred liabilities -8.35%2.02B96.58%2.53B42.97%2.5B7.14%2.7B7.14%2.7B-64.40%2.2B-66.19%1.29B-43.69%1.75B-17.84%2.52B-17.84%2.52B
Other current liabilities 18.73%19.92B2.06%16.41B-7.23%18.79B-9.02%20.54B-9.02%20.54B-14.69%16.78B-32.55%16.08B-17.64%20.25B-9.46%22.58B-9.46%22.58B
Current liabilities 38.78%43.21B26.47%43.82B10.76%40.5B13.42%47.79B13.42%47.79B-29.74%31.14B-26.92%34.65B-6.89%36.56B-1.25%42.14B-1.25%42.14B
Non current liabilities
Long term debt and capital lease obligation -6.77%56.92B-7.53%56.73B96.75%60.48B89.50%60.5B89.50%60.5B92.87%61.05B84.98%61.36B-10.69%30.74B-8.15%31.93B-8.15%31.93B
-Long term debt -6.77%56.92B-7.53%56.73B96.75%60.48B89.50%60.5B89.50%60.5B92.87%61.05B84.98%61.36B-10.69%30.74B-8.15%31.93B-8.15%31.93B
Non current deferred liabilities 91.82%2.16B80.76%2.23B-12.75%931M-37.44%640M-37.44%640M82.63%1.13B120.79%1.23B62.90%1.07B193.12%1.02B193.12%1.02B
Employee benefits -4.29%2.07B-6.59%2.04B-4.73%2.08B-3.69%2.17B-3.69%2.17B-26.82%2.17B-32.94%2.18B-37.64%2.18B-39.58%2.25B-39.58%2.25B
Derivative product liabilities --1.08B--773M-14.08%830M8.34%1.04B8.34%1.04B---------22.10%966M-33.31%959M-33.31%959M
Other non current liabilities 9.32%15.57B20.07%16.09B16.25%15.12B25.47%16.54B25.47%16.54B16.37%14.24B18.49%13.4B23.79%13.01B35.28%13.18B35.28%13.18B
Total non current liabilities -3.43%83.71B-2.12%84.4B52.27%88.04B51.17%89.42B51.17%89.42B49.08%86.68B42.74%86.23B-6.57%57.82B-3.57%59.15B-3.57%59.15B
Total liabilities 7.72%126.92B6.07%128.22B36.19%128.54B35.47%137.21B35.47%137.21B14.99%117.82B12.11%120.88B-6.70%94.38B-2.62%101.29B-2.62%101.29B
Shareholders'equity
Share capital 0.42%480M0.42%480M0.42%480M0.42%478M0.42%478M0.42%478M0.42%478M0.42%478M0.63%476M0.63%476M
-common stock 0.42%480M0.42%480M0.42%480M0.42%478M0.42%478M0.42%478M0.42%478M0.42%478M0.63%476M0.63%476M
-Preferred stock --------------0--0--------------0--0
Retained earnings -4.23%121.06B-9.47%116.6B-7.46%121.32B-5.81%118.35B-5.81%118.35B2.80%126.41B10.45%128.8B17.90%131.1B21.53%125.66B21.53%125.66B
Paid-in capital 1.06%93.48B0.94%93.2B0.92%93B0.90%92.63B0.90%92.63B1.24%92.5B1.26%92.33B1.44%92.15B1.34%91.8B1.34%91.8B
Less: Treasury stock 0.24%114.76B0.24%114.76B0.25%114.76B0.45%114.49B0.45%114.49B0.47%114.49B0.48%114.48B0.48%114.47B2.34%113.97B2.34%113.97B
Gains losses not affecting retained earnings -0.05%-7.97B3.53%-7.82B6.41%-7.76B4.13%-7.96B4.13%-7.96B3.14%-7.97B-13.81%-8.1B-34.63%-8.29B-40.84%-8.3B-40.84%-8.3B
Other equity interest 0.00%1M----------------200.00%1M----0.00%-1M--------
Total stockholders'equity -4.80%92.29B-11.43%87.7B-8.60%92.28B-6.95%89.01B-6.95%89.01B4.65%96.93B13.54%99.02B22.50%100.97B23.91%95.66B23.91%95.66B
Noncontrolling interests 0.74%272M0.36%275M3.76%276M7.03%274M7.03%274M4.25%270M4.98%274M1.92%266M-2.29%256M-2.29%256M
Total equity -4.78%92.56B-11.40%87.98B-8.57%92.56B-6.91%89.29B-6.91%89.29B4.64%97.2B13.52%99.29B22.44%101.24B23.82%95.92B23.82%95.92B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept CAR-T Therapy
CAR-T Therapy
Intraday-1.43%
Infectious Disease
Infectious Disease
Intraday-1.46%
Cancer Research
Cancer Research
Intraday-2.68%